BaronAD, BrechtelG, WallaceP, EdelmanSV.Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol1988;255:E769–74.
2.
FerranniniE, BuzzigoliRD, GioricoMA, OlegginiL, GraziadeiL, PedrinelliR, BrandiL, BevilacquaS.Insulin resistance in essential hypertension. N Engl J Med1987;317:350–7.
3.
ReavenGM.Role of insulin resistance in human disease. Diabetes1988;37:1595–607.
4.
LawsA, ReavenGM.Insulin resistance and risk factors for coronary heart disease. In: FerranniniE, editor. Clinical endocrinology and metabolism. London: Bailliere Tindall; 1993:1063–78.
5.
ReavenGM, ChenY-D I, JeppesenJ, MaheuxP, KraussRM.Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest1992;92:141–6.
6.
ZierlerKL.Theory of the use of arteriovenous concentration dif-ferences for measuring metabolism in steady and nonsteady state. J Clin Invest1961;40:2111–25.
7.
CushmanS, WardzalaL.Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell: apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem1980;255:4728–62.
8.
BirnbaumMJ.The insulin-sensitive glucose transporter. Int Rev Cytol1992;137A:239–97.
9.
LaaksoM, EdelmanSV, BrechtelG, BaronAD.Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest1990;85:1844–52.
10.
LaaksoM, EdelmanSV, BrechtelG, BaronAD.Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes1992;41:1076–83.
11.
BaronAD, BrechtelG.Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol1993;265:E61–7.
12.
MoncadaS, PalmerRMJ, HiggsEA.The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension1988;12:365–72.
13.
FurchgottRF, ZawadskiJV.The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980;288:373–6.
14.
ReesDD, PalmerRMJ, MoncadaS.Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA1989;86:3375–8.
15.
VallanceP, CollierJ, MoncadaS.Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet1989;ii:997–1000.
16.
SteinbergHO, BrechtelG, JohnsonA, FinebergN, BaronAD.Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest1994;94:1172–9.
17.
ScherrerU, RandinD, VollenweinderP, VollenweinderL, NicodP.Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest1994;94:2511–5.
18.
BaronAD, SteinbergHO, ChakerH, LeamingR, JohnsonA, BrechtelG.Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest1995;96:786–92.
19.
BaronAD, Brechtel-HookG, JohnsonA, HardinD.Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension1993;21:129–35.
20.
BaronAD.Hemodynamic actions of insulin. Am J Physiol1994;267:E187–202.
21.
SteinbergH, ChakerH, LeamingR, JohnsonA, BrechtelG, BaronAD.Obesity/insulin resistance is associates with endothelial dys-function. Implications for the syndrome of insulin resistance. J Clin Invest. In press.
22.
PanzaJA, QuyyumiAA, BrushJEJr, EpsteinSE.Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med1990;323(1):227.
23.
CreagerMA, CookeJP, MendelsohnME, GallagherSJ, ColemanSM, LoscalzoJ, DzauVJ.Impaired vasodilation of forearm resistant vessels in hypercholesterolemic humans. J Clin Invest1990;86:228–34.
24.
VanceJR, AnggardEE, BottingRM.Regulatory functions of the vascular endothelium. N Engl J Med1990;323(1):27–36.
25.
MoncadaS, HiggsA.Mechanisms of disease: the L-arginine-nitric oxide pathway. N Engl J Med1993;329:2002–12.
26.
LoscalzoJ, WelchG.Nitric oxide and its role in the cardiovascu-lar system. Prog Cardiovasc Dis1995;38:87–104.
27.
RadomskiMW, PalmerRMJ, MoncadaS.The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol1987;92:639–46.
28.
SimonDI, StamlerJS, LohE, LoscalzoJ, FrancisSA, CreagerMA.Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharmacol1995;26:339–42.
29.
Lamon-FavaS, JimenezD, ChristianJC, FabsitzRR, ReedT, CarmelliD, CastelliWP, OrdovasMJ, WilsonPWF, SchaeferEJ.The NHLBI twin study: heritability of apoliprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein (a). Atherosclerosis1991;91:97–106.
30.
LemboG, RendinaV, IaccarinoG, LamenzaF, CondorelliG, RosielloG, TrimarcoB.Insulin does not modulate reflex forearm sym-pathetic vasoconstriction in patients with essential hypertension. J Hypertens1993;11:S272–3.
31.
SteinbergD.Role of oxidized LDL and antioxidants in athero-sclerosis. Adv Exp Med Biol1995;369:39–48.
32.
BaronAD, BrechtelG, JohonsonA, FinebergN, HenryDP, SteinbergHO.Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men. J Clin Invest1994;93:2453–62.
